Juniper Publishers : The Use of HE-4 in Gynecological Cancers

  JUNIPER PUBLISHERS- JOURNAL OF GYNECOLOGY AND WOMEN’S HEALTH


                              Journal of Gynecology and Women’s Health-Juniper Publishers

 

Authored by  Sinem Ayse Duru Coteli*

 

Abstract

Diagnosing cancer at an early stage and also distinguishing malignancy from benign disease are important areas of medical research. Using tumor biomarkers is a noninvasive procedure for this purpose. HE-4 is a novel biomarker that can be used in gynecologic oncology for early diagnosis, determination of prognosis and follow up. The use of HE-4 in ovarian and endometrial cancers is summarized in this review.

Keywords: HE-4; Ovarian carcinoma; Endometrial carcinoma

Introduction

Human epididymis protein 4 (HE-4) is a whey acidic protein which consists of four disulfide bonds and the gene is located on the short arm of the 20th chromosome [1-3]. It was first discovered on the surface of the epididymal epithelium and has been shown in many other tissues including female reproductive tract [2,4]. In 2006, it was shown that the serum levels of HE-4 was elevated in ovarian, edometrial, lung and breast adenocarcinomas [2]. HE4 is also approved as a biomarker by Food and Drug Administration (FDA) for monitoring ovarian cancer (OC) [1,3]. The recommended upper limit for HE4 is 150pmol/L for premenopausal and postmenopausal women [1]. The main limitation of this cut-off value is that the level of serum HE-4 can differ with increasing age and also HE-4 is cleared through glomerular filtration so the reduced renal functions may alter the results [1,5,6]. Also menstrual cycle fluctuations have been shown with HE-4, in follicular phase the values are reported to be lower [7]. In this review we aimed to briefly summarize the use of biomarker HE-4 in gynecological cancers.

HE-4 and Ovarian Cancer

OC is the leading death from gynecological cancers in developed countries and more than 200.000 new cases are diagnosed world wide annualy [3,8]. Since most of the patients are diagnosed at an advanced stage, OC remains the most lethal gynecologic malignancy. Because of the poor rate of survival, new techniques are needed to detect and screen OC. Novel biomarkers are studied for this purpose. Cancer antigen 125 (CA-125) has been used for screening and for the follow up of patients diagnosed with OC [1,9]. It is the most widely used biomarker in gynecology. However, CA-125 has some limitations in clinical use. The marker can be elevated in some benign gynecological conditions and non gynecological conditions, such as endometriosis, infections, pelvic inflammatory disease, pregnancy, other malignancies and conditions with peritoneal, pleural and pericardial inflamation [1,6,9]. Because of these limitations and the low specificity, new biomarkers have been used for detecting early stages of OC. HE-4 was found to increase the sensitivity and specifity for the detection of OC [10-12]. Also HE-4 was found to be overexpressed in clear cell, endometrioid and serous epithelial ovarian carcinomas [1,13].

As HE-4 is not found to be elavated in other medical conditions like CA-125, it can be used as a marker in the diagnosis of OC. In 2009, Moore et al. used an algorithm combining CA-125, HE-4 and the menopausal status of the patients, which is called the Risk of Malignancy Algorithm (ROMA). With this algorithm 94% of the patients diagnosed with epithelial ovarian cancer were classified as high risk [14]. There have been many articles published since than with HE-4 in detecting OC. In meta-analysis researchers concluded that the sensitivity and specificity of preoperative HE-4 concentration was greater than CA-125, in detecting OC [11,15].

HE-4 has also been studied in OC for its prognostic value. High levels of HE-4 was correlated with poor prognosis in OC with poor progression free survival [3,15]. In a recent meta-analysis, high levels of HE-4 was associated with advanced stage and serous subtypes. HE-4 was not significantly elevated in lymph node metastasis and high grades [15].

High levels of HE-4 was also associated with frequent recurence in OC [16]. HE4 is a new target for chemotherapy response in OC and has role in optimal cytoreduction. If HE-4 levels are measured before first-line chemotherapy in epithelial ovarian carcinoma patients, it can predict the theraphy response [17,18]. It is also suggested that cutt off values for optimal cytoreduction should be calculated, then HE-4 can be used as a surgical outcome predictor [19]. However, the cut off values for HE-4 in the diagnosis and prognosis of OC is still conflicting. More studies are needed for modification of cut off values for premenopausal and postmenopausal women to increase the sensitivity and specifity.

HE-4 in Endometrial Cancer

Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, its insidance is 14.7 and its mortality rate is 2.3 per 100.000 population [20]. Most of the patients are recognised in an early stage and the cure rate is almost 95% in early stage cancers [21]. It is important to diagnose cancers at an early stage for improving prognosis. Tumor markers have been used for this purpose. CA-125 has also been used in EC to stratify the risk groups and to individualize therapy. However, there are conflicts in this area of research. Although high levels of CA-125 was found to be an independent risk factor for poor prognosis, some researches observed no correlation between CA-125 levels and the stage of the disease [22]. Also the sensitivity and the specificity of CA-125 is lower for EC than OC [21]. Several studies have shown that HE4 is a novel sensitive and specific biomarker for EC [23-25].

HE-4 is found to be indicator of poor prognostic factors including deep myometrial invasion and tumor size in EC [25-27]. Deep myometrial invasion has been accepted as a risk factor for lymph node metastasis [28]. Such high risk patients are staged surgically with hysterectomy, bilateral salpigooferectomy and lymphadenectomy. EC is mostly seen in postmenopausal patients with an avarage age of 60, however 8% of EC is seen in patients with younger than age 45 [29]. The main problem of young age in gynecological cancers is the desire for future fertility. As HE-4 is found to be an indicator for myometrial invasion which shows poor prognosis, it can be used to evaluate patients who desire to retain their fertility. On the other hand, HE-4 can be used to avoid over treatment in patients with early stage diseases [27,30].

HE-4 has also been used for determining prognosis and recurrence in EC. Elevated HE-4 level is an independent factor for poor prognosis and overall survival. Besides it is shown that HE-4 can detect recurrence during follow up [31,32]. HE4 levels before treatment for detecting EC is found to be in the range of 50-70pmol/L (78,8% sensitivity and 100% specificity) in a meta analysis [33].

Conclusion

HE-4 is a novel biomarker which can be used both in OC and EC for early diagnosis, determination of prognosis and follow up.

 

For more open access journals in JuniperPublishers please click on: https://juniperpublishers.com/

 

For more articles on Gynecology and Women’s Health please click on: https://juniperpublishers.com/jgwh/

 

 To read more......Fulltext in  Gynecology and Women’s Health in Juniper Publishers

 

https://juniperpublishers.business.site/

 

 

 

Comments

Post a Comment

Popular posts from this blog

Juniper Publishers | Journal of Gynecology and Women’s Health

Image
Infertility Awareness among UK University Students -Journal of Gynecology and Women’s Health-Juniper Publishers JUNIPER PUBLISHERS- JOURNAL OF GYNECOLOGY AND WOMEN’S HEALTH INFERTILITY AWARENESS AMONG UK UNIVERSITY STUDENTS Authored by Harriet Ribbons The average age of a Mother in 2013 was found to be 30 years older than in 2012. The average family size in 2013 was 1.85 children, lower than in 2012. The factors which are seen to influence the number of births, average age of Mothers and the number of children are timing of child bearing, completion of family size, finance, housing, welfare and employment uncertainty. Statistics show that individuals are delaying child bearing and University Students are seen to delay child bearing further. This is the first study of this kind in the UK and will assess attitudes among UK students. In this study we have 181 randomly selected University Students completed a 20 question fertility questionnaire. 96.1% o...
Read more

Juniper Publishers : Dissemination of Pertussis in Pregnant Women of Iran

Image
  JUNIPER PUBLISHERS- JOURNAL OF GYNECOLOGY AND WOMEN’S HEALTH                              Journal of Gynecology and Women’s Health-Juniper Publishers   Authored by Azardokht Tabatabaei*   Abstract Aim: Pertussis is severe illness and high mortality, especially among infants. The aim of this study was to determine the prevalence of Bordetella pertussis in pregnant women in southern part of Tehran. Methods: Total 303 pregnant women who referred to health centers for periodic pregnancy tests were randomly selected during six months in the year 2017. After receiving conscious consent from mothers, 5 milliliter of blood was sampled. A test to determine quantitative values of IgG-pT, IgA-pT by ELISA method was performed on samples. Results: In total, 177 women (58.2%) were serologically infected with Bordetella pertussis. Only...
Read more

Juniper Publishers Indexing Sites List

Image
Juniper Publishers Indexing Sites List   Index Copernicus : All journals may be registered in the ICI World of Journals database. The database gathers information on international scientific journals which is divided into sections: general information, contents of individual issues, detailed bibliography (references) for every publication, as well as full texts of publications in the form of attached files (optional). Within the ICI World of Journals database, each editorial office may access, free of charge, the IT system which allows you to manage your journal's passport: updating journal’s information, presenting main fields of activity and sharing the publications with almost 200 thousand users from all over the world. The idea behind the ICI World of Journals database is to create a place where scientific journals from all over the world would undergo verification for ‘predatory journals’ practices by scientific community. The ICI World of Journals database all...
Read more